Italian pharmaceutical market grows with help of CDP Group

Italian pharmaceutical market grows with help of CDP Group

Through the Export Development Fund, Sace supports Fine Foods, a Lombard leader in the manufacture of drugs and supplements

Rome, November 3, 2016

With Sace’s help, Fine Foods & Pharmaceuticals Ntms aims to double production and expand in international markets. Sace, a CDP Group company,  is working on behalf of the company with its headquarters in the northern Italian Lombardy region through its Export Development Fund – an instrument that opens the capital market for Italian exporters.

The Fund has underwritten a 10 million euro bond. The bond, with a  seven-year maturity, was issued by Fine Foods & Pharmaceuticals Ntm and guaranteed by Sace. Due to this operation, the leading company in the production of medicines and supplements (nutraceuticals), will finance the construction of two new plants to increase production and focus on developing international markets.

The operation is in line with market trends: the products represent an Italian export niche, with 22 billion euros of sales in 2015, and represent a high international growth potential. The good performance of recent years and the evolution of consumer habits have opened up exciting opportunities for this sector in markets such as Germany, Spain, Belgium, the US and China.

CDP Group is part of this positive path, supporting the growth of Fine Foods & Pharmaceuticals Ntm, a company with a portfolio of 150 customers, 77 production lines, 500 employees and a 2015 turnover of 102 million euros, representing a market reference point, boasting a strategic relationship of solid cooperation with major multinationals in the global economic system.